Intellipharmaceutics Announces FDA Approval for 500 mg and 750 mg Generic Glucophage® XR [Canadian Business Journal (Canada)]
INTELLIPHARMACEUTICS (IPCI)
Last intellipharmaceutics earnings: 10/15 05:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.intellipharmaceutics.com
Company Research
Source: Canadian Business Journal
Intellipharmaceutics Announces FDA Approval for 500 mg and 750 mg Generic Glucophage® XR TORONTO, Feb. 24, 2017 (GLOBE NEWSWIRE) — Intellipharmaceutics International Inc. (Nasdaq: IPCI ) (TSX: I ) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs announced that the Company today received final approval from the U.S. Food and Drug Administration (“FDA”) for the Company’s abbreviated new drug application (“ANDA”) for metformin hydrochloride extended release tablets in the 500 mg and 750 mg strengths. The Company’s newly approved product is a generic equivalent for the corresponding strengths of the branded product Glucophage® XR sold in the United States by Bristol-Myers Squibb. Dr. Isa Odidi, the CEO and a co-founder of Intellipharmaceutics, stated, “FDA approval of our application for a generic version of Glucophag
Show less
Read more
Impact Snapshot
Event Time:
IPCI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IPCI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IPCI alerts
High impacting INTELLIPHARMACEUTICS news events
Weekly update
A roundup of the hottest topics